FGF23 is secreted predominantly by osteocytes to regulate phosphate and 1,25-dihydroxyvitamin D. In the early stages of CKD, bone [1] and circulating [2–5] FGF23 levels increase, and continue to rise as CKD progresses and glomerular filtration rate declines. Here, FGF23 is linked to chronic kidney disease.